With more top neurologists and neurosurgeons than any other hospital in the nation, New York’s #1 neurological program is innovating treatments for brain tumors, epilepsy, strokes, and spinal disorders.
We offer a wide range of treatments for spinal disorders and treat more brain tumors than any other center in New York. We have two designated Level 4 Comprehensive Epilepsy Centers that provide our complex epilepsy patients with the highest-level of medical and surgical care. Our mobile stroke units, equipped with the advanced technologies of an ED, continue to push the boundaries of comprehensive care for all patients.
Neurology and Neurosurgery
The Report on Clinical and Scientific Innovations in Neurology and Neurosurgery highlights the work of NewYork-Presbyterian physicians and scientists in glioblastoma, Alzheimer’s disease, movement disorders, epilepsy, and spinal care.
The Brain: A New Normal After Menopause
Using multi-modality neuroimaging, Weill Cornell Medicine neurology faculty at NewYork-Presbyterian Hospital reveal menopause is a dynamic neurological transition that significantly impacts brain structure, connectivity, and the metabolic profile during midlife endocrine aging of the female brain.
A New Application for Focused Ultrasound
NewYork-Presbyterian Hospital’s neurosurgeons are applying their expertise in focused ultrasound to penetrate the blood-brain barrier and provide new pathways for drug delivery to extend and improve life for patients with glioblastoma and Alzheimer’s disease.
A Multidimensional Treatment Approach to Spinal Tumors
Neurosurgeons, interventional neuroradiologists, and neuro-oncologists at NewYork-Presbyterian Hospital are advancing care for benign and malignant spinal tumors through a comprehensive and multidisciplinary strategic approach.
Taking Spine Surgery to New Heights
At NewYork-Presbyterian Hospital, patients find world-renowned spine surgeons representing the fields of neurosurgery and orthopedic surgery. These top specialists offer extraordinary expertise and experience with leading-edge surgical techniques, from endovascular options to the most complex spinal deformity surgeries.
Confronting the Challenges of Glioblastoma Treatment
Neurosurgeons and neuro-oncologists at NewYork-Presbyterian Hospital are pioneering new methods to address two major hurdles to successful treatment – getting past the blood-brain barrier to deliver drugs and incorporating immunotherapy in a cancer that is particularly resistant to this form of treatment.
Multiple Sclerosis: Rethinking How It Begins and Why It Progresses
Physician-scientists at NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Weill Cornell are pursuing research that is yielding a better understanding of what triggers multiple sclerosis, how the disease progresses, and furthers therapeutic options.
Neurosurgeons Advance Applications of Minimally Invasive Techniques for Epilepsy
Patients with refractory epilepsy are finding new hope at NewYork-Presbyterian/
Innovating Minimally Invasive Access to the Brain and Spine
Neurosurgeons at NewYork-Presbyterian/
Cerebral Organoids: Personalizing Glioblastoma Treatment
A neuro-oncologist at NewYork-Presbyterian/
A Renowned Center for Neurology Care and Research
As the destination of choice for patients with neurologic diseases and disorders, NewYork-Presbyterian/
Addressing the Ongoing Challenge of Glioblastoma
Glioblastoma is the most prevalent and most aggressive malignant brain tumors in adults. The neurospecialists at NewYork-Presbyterian/
Pushing the Boundaries for Brain Tumor Treatment
The neuro-oncologists at the Weill Cornell Brain and Spine Center are pushing the boundaries of treatment for patients with brain tumors by using the newest treatment modalities, including awake mapping, imaging techniques, and microsurgery.
The Gamma Knife Evolution Continues
In its 50-year history, the Gamma Knife has proven to be one of the most significant noninvasive technologies available to treat benign and malignant brain lesions and disorders.
Study Clarifies ApoE4’s Role in Dementia
In a study published in journal Nature Communications, researchers at Weill Cornell Medicine identify a protein that increases the risk of cognitive impairment.
Alzheimer’s and Prevention: Who Would Have Thought?
A family history of Alzheimer’s disease has been the driving force for a NewYork-Presbyterian/
HIFU: Heralding New Hope for Movement Disorders
A Commitment to Conquering ALS
At the Eleanor and Lou Gehrig ALS Center at NewYork-Presbyterian/
Newsletters for Medical Professionals
2021 Issue 3
2021 Issue 2
2021 Issue 1
- A Wake-Up Call for Addressing Sleep Deprivation
- Dr. E. Sander Connolly Jr. Named Neurosurgeon-in-Chief at Columbia
- Donald O. Quest, MD, Honored for Lifetime of Service
2020 Issue 1
- MMA Embolization: A Novel Approach to Managing Subdural Hematoma
- Dr. Mitchell Elkind Named President of American Heart Association
- New Evidence of Cognition in Patients with Severe Brain Injury
- Validating an MRI Measure of Pathology in Alzheimer’s Disease
- Advancing Alzheimer’s Disease Research through Multi-omics Data
- Strategic and Multipronged Approaches to Spinal Tumors
- Dr. Cigdem Akman Leads Child Neurology at Columbia
- Study Clarifies ApoE4’s Role in Dementia
- Targeting Endosomal Trafficking in Alzheimer’s Disease
- Alzheimer’s and Prevention: Who Would Have Thought?
- HIFU: Heralding New Hope for Movement Disorders
- A Commitment to Conquering ALS
- NIH Director’s Pioneer Award Bestowed on Weill Cornell Researcher
- Comprehensive Programs Address Brain and CNS Metastases
- Multidisciplinary Central Nervous System Metastases Clinic
- Brain Metastases Clinic
- Expanding Expertise in Neurology and Neurosurgery
- Making Strides in the Treatment of Hemorrhagic Stroke
- Mobile Stroke Treatment Unit Hastens Early Intervention